Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells

• 主要な著者: Xu Zhu (著者), Xiaomeng Shen (著者), Jun Qu (著者), Robert M. Straubinger (著者), William J. Jusko (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2018-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Pancreatic cancer is characterized by mutated signaling pathways and a high incidence of drug resistance. Comprehensive, large-scale proteomic analysis can provide a system-wide view of signaling networks, assist in understanding drug mechanisms of action and interactions, and serve as a useful tool...